| Disaggregation of Revenue [Table Text Block] |
Disaggregated revenue by primary geographical markets and major goods and service lines are as follows: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Reportable Segments | | Three Months Ended | | July 5, 2026 | | June 29, 2025 | | Life Sciences | | Diagnostics | | Total | | Life Sciences | | Diagnostics | | Total | | (In thousands) | | Primary geographical markets | | | | | | | | | | | | | Americas | $ | 183,575 | | | $ | 142,008 | | | $ | 325,583 | | | $ | 197,071 | | | $ | 126,509 | | | $ | 323,580 | | | Europe | 89,478 | | | 139,563 | | | 229,041 | | | 84,298 | | | 119,334 | | | 203,632 | | | Asia | 85,646 | | | 89,418 | | | 175,064 | | | 84,529 | | | 108,543 | | | 193,072 | | | $ | 358,699 | | | $ | 370,989 | | | $ | 729,688 | | | $ | 365,898 | | | $ | 354,386 | | | $ | 720,284 | | | | | | | | | | | | | | | Major goods/service lines | | | | | | | | | | | | | Life Sciences Solutions | $ | 301,028 | | | $ | — | | | $ | 301,028 | | | $ | 298,052 | | | $ | — | | | $ | 298,052 | | | Software | 57,671 | | | — | | | 57,671 | | | 67,846 | | | — | | | 67,846 | | | Immunodiagnostics | — | | | 214,758 | | | 214,758 | | | — | | | 218,818 | | | 218,818 | | | Reproductive Health | — | | | 156,231 | | | 156,231 | | | — | | | 135,568 | | | 135,568 | | | $ | 358,699 | | | $ | 370,989 | | | $ | 729,688 | | | $ | 365,898 | | | $ | 354,386 | | | $ | 720,284 | |
|